Relationship of glucose regulation to changes in weight: A systematic review and guide to future research

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 5, 2010, Pages 323-335

  Chiu, Ching Ju ^a   Wray, Linda A ^a   Beverly, Elizabeth A ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; Glucose regulation; Systematic review; Weight change

Indexed keywords

GLUCOSE;

BODY WEIGHT; DIABETIC PATIENT; ETHNICITY; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; WEIGHT CHANGE; WEIGHT GAIN; ADULT; AGED; ETHNOLOGY; FEMALE; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RESEARCH; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RESEARCH; WEIGHT GAIN; WEIGHT LOSS;

EID: 77954151271     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1095     Document Type: Review

References (75)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-1200. (Pubitemid 33015548)
2. Brancati FL, Wang NY, Mead LA, Liang KY, Klag MJ. Body weight patterns from 20 to 49 years of age and subsequent risk for diabetes mellitus: the Johns Hopkins Precursors Study. Arch Intern Med 1999; 159: 957-963.
3. Wannamethee SG, Shaper AG. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 1999; 22: 1266-1272.
4. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997; 146: 214-222. (Pubitemid 27329722)
5. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-969.
6. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132: 501-513. (Pubitemid 20285148)
7. Oguma Y, Sesso HD, Paffenbarger RS Jr, Lee IM. Weight change and risk of developing type 2 diabetes. Obes Res 2005; 13: 945-951.
8. Wannamethee SG, Shaper AG, Walker M. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J Epidemiol Community Health 2005; 59: 134-139. (Pubitemid 40139326)
9. ADA. Standards of medical care in diabetes - 2008. Diabetes Care 2008; 31((Suppl. 1)): S12-S54.
10. Mensing C, Boucher J, Cypress M, et al. National standards for diabetes self-management education. Diabetes Care 2007; 30((Suppl. 1)): S96-S103.
11. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin comparedwith conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
12. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA 1998; 280: 140-146.
13. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Eng J Med 1993; 329: 977-986.
14. Arner P. Control of lipolysis and its relevance to development of obesity in man. Diabetes Metab Rev 1988; 4: 507-515.
15. Felig P. Insulin is themediator of feeding-related thermogenesis: insulin resistance and/or deficiency results in a thermogenic defect which contributes to the pathogenesis of obesity. Clin Physiol 1984; 4: 267-273.
16. Rodin J. Insulin levels, hunger, and food intake: an example of feedback loops in body weight regulation. Health Psychol 1985; 4: 1-24.
17. Jeanrenaud B. Neuroendocrine and metabolic basis of type II diabetes as studied in animal models. Diabetes Metab Rev 1988; 4: 603-614.
18. Noach EL. Appetite regulation by serotoninergic mechanisms and effects of d-fenfluramine. Neth J Med 1994; 45: 123-133.
19. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962; 14: 353-362.
20. Eckel RH. Insulin resistance: an adaptation for weight maintenance. Lancet 1992; 340: 1452-1453.
21. Woods SC, Porte D Jr, Bobbioni E, et al. Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am J Clin Nutr 1985; 42: 1063-1071.
22. Swinburn BA, Nyomba BL, Saad MF, et al. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991; 88: 168-173.
23. Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW. Obesity, diabetes and the central nervous system. Diabetologia 1998; 41: 863-881.
24. Schwartz MW, Niswender KD. Adiposity signaling and biological defense against weight gain: absence of protection or central hormone resistance? J Clin Endocrinol Metab 2004; 89: 5889-5897.
25. Wray LA, Blaum C, Ofstedal MB, Herzog R. Diabetes dianosis and weight loss in middle-aged adults. Res Aging 2004; 26: 62-81.
26. Nafziger AN, Lindvall K, Norberg M, et al. Who is maintaining weight in a middle-aged population in Sweden? A longitudinal analysis over 10 years. BMC Public Health 2007; 7: 108.
27. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes - causes, effects and coping strategies. Diabetes Obes Metab 2007; 9: 799-812. (Pubitemid 47555203)
28. de Fine Olivarius N, Andreasen AH, Siersma V, Richelsen B, Beck-Nielsen H. Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus. Diabetologia 2006; 49: 2058-2067. (Pubitemid 44168472)
29. Chaudhry ZW, Gannon MC, Nuttall FQ. Stability of body weight in type 2 diabetes. Diabetes Care 2006; 29: 493-497.
30. Leventhal H, Nerenz DR, Steele DJ. Illness representations and coping with health threats. In Handbook of Psychology and Health, Baum A, Taylor SE, Singer JE (eds). Lawrence Erlbaum Associates: Hilsdale, NJ, 1984; 219-252.
31. Carver CS, Scheier MF. On the self-regulation of behavior. Cambridge University Press: Cambridge, 1998.
32. Zaccardi F, Pitocco D, Ghirlanda G. Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab Res Rev 2009; 25: 199-207.
33. Tong J, Fujimoto WY, Kahn SE, et al. Insulin, C-peptide, and leptin concentrations predict increased visceral adiposity at 5- and 10-year follow-ups in nondiabetic Japanese Americans. Diabetes 2005; 54: 985-990.
34. Mosca CL, Marshall JA, Grunwald GK, Cornier MA, Baxter J. Insulin resistance as a modifier of the relationship between dietary fat intake and weight gain. Int J Obes Relat Metab Disord 2004; 28: 803-812.
35. Lazarus R, Sparrow D, Weiss S. Temporal relations between obesity and insulin: longitudinal data from the Normative Aging Study. Am J Epidemiol 1998; 147: 173-179. (Pubitemid 28060489)
36. Wing RR, Klein R, Moss SE. Weight gain associated with improved glycemic control in population-based sample of subjects with type I diabetes. Diabetes Care 1990; 13: 1106-1109. (Pubitemid 20365901)
37. Shoff SM, Klein R, Moss SE, Klein BE, Cruickshanks KJ. Weight change and glycemic control in a population-based sample of adults with older-onset diabetes. J Gerontol 1998; 53: M27-M32.
38. Ferriss JB, Webb D, Chaturvedi N, Fuller JH, Idzior-Walus B. Weight gain is associated with improved glycaemic control but with adverse changes in plasma lipids and blood pressure isn Type 1 diabetes. Diabet Med 2006; 23: 557-564.
39. Jacob AN, Salinas K, Adams-Huet B, Raskin P. Weight gain in type 2 diabetes mellitus. Diabetes Obes Metab 2007; 9: 386-393. (Pubitemid 46502059)
40. Schwartz MW, Boyko EJ, Kahn SE, Ravussin E, Bogardus C. Reduced insulin secretion: an independent predictor of body weight gain. J Clin Endocrinol Metab 1995; 80: 1571-1576.
41. Sigal RJ, El-Hashimy M, Martin BC, Soeldner JS, Krolewski AS, Warram JH. Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study. Diabetes 1997; 46: 1025-1029. (Pubitemid 27221004)
42. Valdez R, Mitchell BD, Haffner SM, et al. Predictors of weight change in a bi-ethnic population. The San Antonio Heart Study. Int J Obes Relat Metab Disord 1994; 18: 85-91.
43. Hoag S, Marshall JA, Jones RH, Hamman RF. High fasting insulin levels associated with lower rates of weight gain in persons with normal glucose tolerance: the San Luis Valley Diabetes Study. Int J Obes Relat Metab Disord 1995; 19: 175-180.
44. Mayer-Davis EJ, Kirkner GJ, Karter AJ, Zaccaro DJ. Metabolic predictors of 5-year change in weight and waist circumference in a triethnic population: the insulin resistance atherosclerosis study. Am J Epidemiol 2003; 157: 592-601.
45. Wedick NM, Mayer-Davis EJ, Wingard DL, Addy CL, Barrett- Connor E. Insulin resistance precedes weight loss in adults without diabetes: the Rancho Bernardo Study. Am J Epidemiol 2001; 153: 1199-1205.
46. Boule NG, Chaput JP, Doucet E, et al. Glucose homeostasis predicts weight gain: prospective and clinical evidence. Diabetes Metab Res Rev 2007; 24: 123-129.
47. Hodge AM, Dowse GK, Alberti KG, Tuomilehto J, Gareeboo H, Zimmet PZ. Relationship of insulin resistance to weight gain in nondiabetic Asian Indian, Creole, and Chinese Mauritians. Mauritius Non-communicable Disease Study Group. Metab Clin Exp 1996; 45: 627-633.
48. Folsom AR, Vitelli LL, Lewis CE, Schreiner PJ, Watson RL, Wagenknecht LE. Is fasting insulin concentration inversely associated with rate of weight gain? Contrasting findings from the CARDIA and ARIC study cohorts. Int J Obes Relat Metab Disord 1998; 22: 48-54.
49. Gould AJ, Williams DE, Byrne CD, Hales CN, Wareham NJ. Prospective cohort study of the relationship of markers of insulin resistance and secretion with weight gain and changes in regional adiposity. Int J Obes Relat Metab Disord 1999; 23: 1256-1261.
50. Boyko EJ, Leonetti DL, Bergstrom RW, Newell-Morris L, Fujimoto WY. Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men. Diabetes 1996; 45: 1010-1015.
51. Howard BV, Adams-Campbell L, Allen C, et al. Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups. Int J Obes Relat Metab Disord 2004; 28: 1039-1047.
52. Zavaroni I, Zuccarelli A, Gasparini P, Massironi P, Barilli A, Reaven GM. Can weight gain in healthy, nonobese volunteers be predicted by differences in baseline plasma insulin concentration? J Clin Endocrinol Metab 1998; 83: 3498-3500.
53. Silver RJ, Mehta S, Soeldner JS, Martin BC, Warram JH, Goldfine AB. Acute insulin secretion as a predictor ofweight gain in healthy humans. Obesity (Silver Spring) 2006; 14: 67-72.
54. Knowler WC, Pettitt DJ, Savage PJ, Bennett PH. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 1981; 113: 144-156.
55. Looker HC, Knowler WC, Hanson RL. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 2001; 24: 1917-1922. (Pubitemid 33716501)
56. Lustman PJ, Griffith LS, Clouse RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997; 59: 241-250.
57. Pouliot MC, Despres JP, Nadeau A, et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992; 41: 826-834.
58. Despres JP, Nadeau A, Tremblay A, et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989; 38: 304-309.
59. Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2001; 2: 282-286.
60. Kim JK, Michael MD, Previs SF, et al. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 2000; 105: 1791-1797.
61. Hansen BC, Bodkin NL. Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. Am J Physiol 1990; 259: R612-R617.
62. Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006; 147: 4160-4168.
63. Mohlig M, Spranger J, Otto B, Ristow M, Tschop M, Pfeiffer AF. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 2002; 25: RC36-RC38.
64. Malabu UH, McCarthy HD, McKibbin PE, Williams G. Peripheral insulin administration attenuates the increase in neuropeptide Y concentrations in the hypothalamic arcuate nucleus of fasted rats. Peptides 1992; 13: 1097-1102. (Pubitemid 23010901)
65. Schwartz MW, Sipols AJ, Marks JL, et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 1992; 130: 3608-3616.
66. Ettinger WH Jr, Sun WH, Binkley N, Kouba E, Ershler W. Interleukin-6 causes hypocholesterolemia in middle-aged and old rhesus monkeys. J Gerontol 1995; 50: M137-M140.
67. Baura GD, Foster DM, Porte D Jr, et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest 1993; 92: 1824-1830.
68. Schwartz MW, Bergman RN, Kahn SE, et al. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest 1991; 88: 1272-1281.
69. Ikeda H, West DB, Pustek JJ, et al. Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 1986; 7: 381-386. (Pubitemid 17217670)
70. Spanswick D, Smith MA, Mirshamsi S, Routh VH, Ashford ML. Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 2000; 3: 757-758. (Pubitemid 30485698)
71. Park S, Hong SM, Ahn IS. Long-term intracerebroventricular infusion of insulin, but not glucose, modulates body weight and hepatic insulin sensitivity by modifying the hypothalamic insulin signaling pathway in type 2 diabetic rats. Neuroendocrinology 2009; 89: 387-399.
72. Arner P. Obesity and insulin resistance in Swedish subjects. Diabet Med 1996; 13: S85-S86. (Pubitemid 26316206)
73. Jenkins KR, Fultz NH, Fonda SJ, Wray LA. Patterns of body weight in middle-aged and older Americans, by gender and race, 1993-2000. Soz Praventivmed 2003; 48: 257-268.
74. Ishikawa-Takata K, Ohta T, Moritaki K, Gotou T, Inoue S. Obesity, weight change and risks for hypertension, diabetes and hypercholesterolemia in Japanese men. Eur J Clin Nutr 2002; 56: 601-607. (Pubitemid 34822898)
75. Jenkins KR, Johnson NE, Ofstedal MB. Patterns and associations of body weight among older adults in two Asian societies. J Cross Cult Gerontol 2007; 22: 83-99.